Genetic modification of human embryonic stem cells

Biotechnology and Genetic Engineering Reviews

Volumn 24, Issue 1, 2007, Pages 297-310

  Xia, Xiaofeng ^a   Zhang, Su Chun ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMBRYONIC STEM CELLS; GENETIC MODIFICATIONS;

STEM CELLS;

BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN;

CELL DEATH; CELL DIFFERENTIATION; DNA MODIFICATION; EMBRYONIC STEM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; REVIEW; RNA INTERFERENCE; TRANSGENICS; UNTRANSLATED REGION;

EID: 35648962962     PISSN: 02648725     EISSN: 20465556     Source Type: Journal    
DOI: 10.1080/02648725.2007.10648105     Document Type: Article

References (68)

1. Adachi, K., Kawase, E., Yasuchika, K., Sumi, T., Nakatsuji, N., and Suemori, H., 2006. Establishment of the Gene-Inducible System in Primate Embryonic Stem Cell Lines. Stem Cells, 24:2566–2572.
2. Anderson, K. V., and Ingham, P. W., 2003. The transformation of the model organism:a decade of developmental genetics. Nat. Genet, 33:285–293.
3. Arber, S., Han, B., Mendelsohn, M., Smith, M., Jessell, T. M., and Sockanathan, S., 1999. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron, 23:659–674.
4. Bedell, M. A., Jenkins, N. A., and Copeland, N. G., 1997a. Mouse models of human disease. Part I:techniques and resources for genetic analysis in mice. Genes Dev, 11:1–10.
5. Bedell, M. A., Largaespada, D. A., Jenkins, N. A., and Copeland, N.G., 1997b. Mouse models of human disease. Part II:recent progress and future directions. Genes Dev, 11:11–43.
6. Boiani, M., and Scholer, H. R., 2005. Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell Biol, 6:872–84.
7. Bonner-Weir, S., and Weir, G. C., 2005. New sources of pancreatic beta-cells. Nat. Biotechnol, 23:857–861.
8. Chang, J. C., Ye, L., and Kan, Y. W., 2006. Correction of the sickle cell mutation in embryonic stem cells. Proc. Natl. Acad. Sci. USA, 103:1036–1040.
9. Cherry, S. R., Biniszkiewicz, D., van Parijs, L., Baltimore, D., and Jaenisch, R., 2000. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol. Cell. Biol, 20:7419–7426.
10. Cockrell, A. S., and Kafri, T., 2003. HIV-1 vectors:fulfillment of expectations, further advancements, and still a way to go. Curr. HIV Res, 1:419–439.
11. Costa, M., Dottori, M., Ng, E., Hawes, S. M., Sourris, K., Jamshidi, P., Pera, M. F., Elefanty, A. G., and Stanley, E. G., 2005. The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat. Methods, 2:259–260.
12. Darr, H., Mayshar, Y., and Benvenisty, N., 2006. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development, 133:1193–1201.
13. Drukker, M., Dhara, S.K., and Benvenisty, N., 2005. “ Genetic engineering of human embryonic stem cells ”. In Human Embryonic Stem Cells, 215–229. Bios Scientific Publishers.
14. Dunnett, S. B., Bjorklund, A., and Lindvall, O., 2001. Cell therapy in Parkinson's disease - stop or go?. Nat. Rev. Neurosci, 2:365–369.
15. Eiges, R., 2006. Genetic manipulation of human embryonic stem cells by transfection. Methods Mol. Biol, 331:221–239.
16. Eiges, R., Schuldiner, M., Drukker, M., Yanuka, O., Itskovitz-Eldor, J., and Benvenisty, N., 2001. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol, 11:514–518.
17. Evans, M. J., and Kaufman, M. H., 1981. Establishment in culture of pluripotential cells from mouse embryos. Nature, 292:154–156.
18. Frohman, M. A., and Martin, G. R., 1989. Cut, paste, and save:new approaches to altering specific genes in mice. Cell, 56:145–147.
19. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H., 1995. Transcriptional activation by tetracyclines in mammalian cells. Science, 268:1766–1769.
20. Gresch, O., Engel, F. B., Nesic, D., Tran, T.T., England, H. M., Hickman, E. S., Korner, I., Gan, L., Chen, S., Castro-Obregon, S., Hammermann, R., Wolf, J., Muller-Hartmann, H., Nix, M., Siebenkotten, G., Kraus, G., and Lun, K., 2004. New non-viral method for gene transfer into primary cells. Methods, 33:151–163.
21. Gropp, M., Itsykson, P., Singer, O., Ben-Hur, T., Reinhartz, E., Galun, E., and Reubinoff, B. E., 2003. Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol. Ther, 7:281–287.
22. Gu, H., Zou, Y. R., and Rajewsky, K., 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell, 73:1155–1164.
23. Guillaume, D. J., Johnson, M.A., Li, X.J., and Zhang, S.C., 2006. Human ES cell-Derived neural progenitors develop into neurons and integrate into the host brain. Journal of Neuroscience Research, 84:1165–1176.
24. Hannon, G. J., 2002. RNA interference. Nature, 418:244–251.
25. Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Levorse, J., DeCoste, C., Schafer, X., Lun, Y., and Lemischka, I. R., 2006. Dissecting self-renewal in stem cells with RNA interference. Nature, 442:533–538.
26. Kaufman, D. S., Hanson, E. T., Lewis, R. L., Auerbach, R., and Thomson, J. A., 2001. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 98:10716–10721.
27. Kawabata, K., Sakurai, F., Koizumi, N., Hayakawa, T., and Mizuguchi, H., 2006. Adenovirus vector-mediated gene transfer into stem cells. Mol. Pharm, 3:95–103.
28. Kawabata, K., Sakurai, F., Yamaguchi, T., Hayakawa, T., and Mizuguchi, H., 2005. Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors. Mol. Ther, 12:547–554.
29. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz-Eldor, J., and Gepstein, L., 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest, 108:407–414.
30. Kobayashi, N., Rivas-Carrillo, J. D., Soto-Gutierrez, A., Fukazawa, T., Chen, Y., Navarro-Alvarez, N., and Tanaka, N., 2005. Gene delivery to embryonic stem cells. Birth Defects Res. C. Embryo Today, 75:10–18.
31. Koller, B. H., Hagemann, L. J., Doetschman, T., Hagaman, J. R., Huang, S., Williams, P. J., First, N. L., Maeda, N., and Smithies, O., 1989. Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA, 86:8927–8931.
32. Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S.Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.Y., Palfi, S., Roitberg, B.Z., Brown, W. D., Holden, J. E., Pyzalski, R., Taylor, M. D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N., and Aebischer, P., 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290:767–773.
33. Kyba, M., Perlingeiro, R. C., and Daley, G. Q., 2002. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell, 109:29–37.
34. Laker, C., Meyer, J., Schopen, A., Friel, J., Heberlein, C., Ostertag, W., and Stocking, C., 1998. Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J. Virol, 72:339–348.
35. Lakshmipathy, U., Pelacho, B., Sudo, K., Linehan, J. L., Coucouvanis, E., Kaufman, D. S., and Verfaillie, C. M., 2004. Efficient transfection of embryonic and adult stem cells. Stem Cells, 22:531–543.
36. Lavon, N., Yanuka, O., and Benvenisty, N., 2004. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation, 72:230–238.
37. Lavon, N., Yanuka, O., and Benvenisty, N., 2006. The effect of overexpression of pdx1 and foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells, 24:1923–1930.
38. Levenberg, S., Golub, J. S., Amit, M., Itskovitz-Eldor, J., and Langer, R., 2002. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 99:4391–4396.
39. Levenstein, M. E., Ludwig, T. E., Xu, R. H., Llanas, R. A., VanDenHeuvel-Kramer, K., Manning, D., and Thomson, J. A., 2006. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells, 24:568–574.
40. Li, X. J., Du, Z. W., Zarnowska, E. D., Pankratz, M., Hansen, L. O., Pearce, R. A., and Zhang, S. C., 2005. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol, 23:215–221.
41. Liu, Y. P., Dambaeva, S. V., Dovzhenko, O. V., Garthwaite, M. A., and Golos, T. G., 2005. Stable plasmid-based siRNA silencing of gene expression in human embryonic stem cells. Stem Cells Dev, 14:487–492.
42. Ma, Y., Ramezani, A., Lewis, R., Hawley, R. G., and Thomson, J. A., 2003. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells, 21:111–117.
43. Martin, G. R., 1981. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA, 78:7634–7638.
44. Mohr, J. C., de Pablo, J. J., and Palecek, S. P., 2006. Electroporation of human embryonic stem cells:Small and macromolecule loading and DNA transfection. Biotechnol. Prog, 22:825–834.
45. Muotri, A. R., Nakashima, K., Toni, N., Sandler, V. M., and Gage, F. H., 2005. Development of functional human embryonic stem cell-derived neurons in mouse brain. Proc. Natl. Acad. Sci. USA, 102:18644–18648.
46. Nakano, T., Windrem, M., Zappavigna, V., and Goldman, S. A., 2005. Identification of a conserved 125 base-pair Hb9 enhancer that specifies gene expression to spinal motor neurons. Dev. Biol, 283:474–485.
47. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D., 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272:263–267.
48. Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E., Bruses, J., Topf, N., Harrison, N. L., and Studer, L., 2004. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA, 101:12543–12548.
49. Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., and Ben-Hur, T., 2001. Neural progenitors from human embryonic stem cells. Nat. Biotechnol, 19:1134–1140.
50. Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A., and Bongso, A., 2000. Embryonic stem cell lines from human blastocysts:somatic differentiation in vitro. Nat. Biotechnol, 18:399–404.
51. Rideout, W. M., 3rd, Hochedlinger, K., Kyba, M., Daley, G.Q., and Jaenisch, R., 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell, 109:17–27.
52. Russell, W. C., 2000. Update on adenovirus and its vectors. J Gen Virol, 81:2573–604.
53. Siemen, H., Nix, M., Endl, E., Koch, P., Itskovitz-Eldor, J., and Brustle, O., 2005. Nucleofection of human embryonic stem cells. Stem Cells Dev, 14:378–383.
54. Silani, V., Cova, L., Corbo, M., Ciammola, A., and Polli, E., 2004. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet, 364:200–202.
55. Singh Roy, N., Nakano, T., Xuing, L., Kang, J., Nedergaard, M., and Goldman, S. A., 2005. Enhancer-specified GFP-based FACS purification of human spinal motor neurons from embryonic stem cells. Exp. Neurol, 196:224–234.
56. Smith-Arica, J. R., Thomson, A. J., Ansell, R., Chiorini, J., Davidson, B., and McWhir, J., 2003. Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors. Cloning Stem Cells, 5:51–62.
57. Srivastava, D., and Ivey, K. N., 2006. Potential of stem-cell-based therapies for heart disease. Nature, 441:1097–1099.
58. Takahashi, K., and Yamanaka, S., 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
59. Thomas, K. R., and Capecchi, M. R., 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell, 51:503–512.
60. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M., 1998. Embryonic stem cell lines derived from human blastocysts. Science, 282:1145–1147.
61. Xia, X., Zhang, Y., Zieth, C.R., and Zhang, S.C., 2007. Transgenes Delivered by Lentiviral Vector are Suppressed in Human Embryonic Stem Cells in a Promoter-Dependent Manner. Stem Cells and Development, (in press)
62. Xiong, C., Tang, D. Q., Xie, C. Q., Zhang, L., Xu, K. F., Thompson, W. E., Chou, W., Gibbons, G. H., Chang, L. J., Yang, L. J., and Chen, Y.E., 2005. Genetic engineering of human embryonic stem cells with lentiviral vectors. Stem Cells Dev, 14:367–377.
63. Xu, R. H., Chen, X., Li, D. S., Li, R., Addicks, G. C., Glennon, C., Zwaka, T. P., and Thomson, J. A., 2002. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol, 20:1261–1264.
64. Xu, R. H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., and Thomson, J. A., 2005. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods, 2:185–190.
65. Yan, Y., Yang, D., Zarnowska, E. D., Du, Z., Werbel, B., Valliere, C., Pearce, R. A., Thomson, J. A., and Zhang, S. C., 2005. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells, 23:781–790.
66. Zaehres, H., Lensch, M. W., Daheron, L., Stewart, S. A., Itskovitz-Eldor, J., and Daley, G. Q., 2005. High-efficiency RNA interference in human embryonic stem cells. Stem Cells, 23:299–305.
67. Zhang, S. C., Wernig, M., Duncan, I. D., Brustle, O., and Thomson, J. A., 2001. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol, 19:1129–1133.
68. Zwaka, T. P., and Thomson, J. A., 2003. Homologous recombination in human embryonic stem cells. Nat. Biotechnol, 21:319–321.